Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldAqemia
Categories
healthcarefoundation-models
HQParis, France
Founded2019
Latest valuation—
Annual Recurring Revenue (ARR)—
Funding to date$100M+
Headcount—
Profitability—
Statusactive
Pricing tierenterprise
Description<cite index="1-6,1-7">Aqemia combines generative AI with deep physics simulations to revolutionize drug discovery at the molecular level. Founded in 2019, it has raised over $100 million and, in 2025, expanded its operations to London as it moves closer to launching clinical trials for its AI-discovered drug candidates.</cite> <cite index="1-5">Reduces the energy consumption of AI training by up to 80%, enabling scalable and eco-friendly AI deployments.</cite>